Liam Berry

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Sulfonamide Bioisosteres of Niclosamide Enhance Antibacterial Activity of Colistin and Bacitracin.

Sulfonamide Bioisosteres of Niclosamide Enhance Antibacterial Activity of Colistin and Bacitracin.

Journal: ChemMedChem

Published: March 05, 2024

Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria.

Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria.

Journal: Antibiotics (Basel, Switzerland)

Published: December 12, 2023

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.

Journal: Drugs

Published: February 13, 2022

Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin.

Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin.

Journal: Frontiers in microbiology

Published: October 27, 2021

A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa.

A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa.

Journal: RSC medicinal chemistry

Published: June 18, 2021

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.

Journal: Drugs

Published: November 28, 2020

Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria.

Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria.

Journal: ACS infectious diseases

Published: May 02, 2020

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.

Journal: Drugs

Published: January 24, 2020

Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria.

Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria.

Journal: MedChemComm

Published: January 29, 2019

Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.

Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.

Journal: Bioorganic chemistry

Published: May 17, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026